In these cases, the illness improved or resolved within an average of three days<\/p>\n<\/h3>\n
<\/b><\/p>\n
<\/b><\/p>\n
TUESDAY, May 24, 2022 (HealthDay News) — COVID-19 can make a comeback after an infected person has gone through a round of Paxlovid, the antiviral used to minimize a bout with the coronavirus, according to an advisory issued Tuesday by the U.S. Centers for Disease Control and Prevention.<\/p>\n
“Recent case reports document that some patients with normal immune response who have completed a five-day course of Paxlovid for laboratory-confirmed infection and have recovered can experience recurrent illness two to eight days later, including patients who have been vaccinated and\/or boosted,” the CDC advisory said.<\/p>\n
In these cases of “COVID-19 rebound,” the illness improved or resolved within an average of three days, without additional anti-COVID-19 treatment, the CDC said.<\/p>\n
A relapse after Paxlovid treatment does not mean the antiviral does not work, the advisory added. “A brief return of symptoms may be part of the natural history of SARS-CoV-2 (the virus that causes COVID-19) infection in some persons, independent of treatment with Paxlovid and regardless of vaccination status,” the CDC said.<\/p>\n
The agency added that “Paxlovid continues to be recommended for early-stage treatment of mild-to-moderate COVID-19 among persons at high risk for progression to severe disease.”<\/p>\n